- call +1-201-465-4211
- email sales@mrinsights.biz
Immunofluorescence Assay(IFA) is a traditional laboratory technique that utilizes fluorescent dyes to identify the presence of antibodies bound to specific antigens. The IFA is very useful to detect the serologic response of a patient who has been exposed to certain infectious agents.
Scope of the Report:
This report studies the Immunofluorescence Assay market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immunofluorescence Assay market by product type and applications/end industries.
In 2017, the indirect immunofluorescence accounted for the largest share of the market. The advantages of this technique, such as its sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence is the key factor increasing the adoption of this technique.
On the basis of disease, the infectious diseases segment accounted for the largest share of the global immunofluorescence assay market in 2017. The large share of this segment is attributed to the increasing prevalence of infectious diseases across the globe and the widespread adoption of immunofluorescence techniques for the study and diagnosis of infectious diseases.
The global Immunofluorescence Assay market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immunofluorescence Assay.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Thermo Fisher
Abcam
Bio-Rad Laboratories
Perkinelmer
Merck Millipore
Inova Diagnostics
Cell Signaling Technology
Medipan
Sino Biological
Danaher
Vector Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Indirect Immunofluorescence
Direct Immunofluorescence
Market Segment by Applications, can be divided into
Cancer
Infectious Diseases
Autoimmune Diseases
Cardiovascular Diseases
Other Diseases
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Immunofluorescence Assay Market Overview
1.1 Product Overview and Scope of Immunofluorescence Assay
1.2 Classification of Immunofluorescence Assay by Types
1.2.1 Global Immunofluorescence Assay Revenue Comparison by Types (2017-2023)
1.2.2 Global Immunofluorescence Assay Revenue Market Share by Types in 2017
1.2.3 Indirect Immunofluorescence
1.2.4 Direct Immunofluorescence
1.3 Global Immunofluorescence Assay Market by Application
1.3.1 Global Immunofluorescence Assay Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Autoimmune Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Other Diseases
1.4 Global Immunofluorescence Assay Market by Regions
1.4.1 Global Immunofluorescence Assay Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Immunofluorescence Assay Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immunofluorescence Assay Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immunofluorescence Assay Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Immunofluorescence Assay Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immunofluorescence Assay Status and Prospect (2013-2023)
1.5 Global Market Size of Immunofluorescence Assay (2013-2023)
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.2 Immunofluorescence Assay Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abcam
2.2.1 Business Overview
2.2.2 Immunofluorescence Assay Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abcam Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories
2.3.1 Business Overview
2.3.2 Immunofluorescence Assay Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bio-Rad Laboratories Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.4 Perkinelmer
2.4.1 Business Overview
2.4.2 Immunofluorescence Assay Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Perkinelmer Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck Millipore
2.5.1 Business Overview
2.5.2 Immunofluorescence Assay Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Millipore Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.6 Inova Diagnostics
2.6.1 Business Overview
2.6.2 Immunofluorescence Assay Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Inova Diagnostics Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cell Signaling Technology
2.7.1 Business Overview
2.7.2 Immunofluorescence Assay Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cell Signaling Technology Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medipan
2.8.1 Business Overview
2.8.2 Immunofluorescence Assay Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medipan Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sino Biological
2.9.1 Business Overview
2.9.2 Immunofluorescence Assay Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sino Biological Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.10 Danaher
2.10.1 Business Overview
2.10.2 Immunofluorescence Assay Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Danaher Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
2.11 Vector Laboratories
2.11.1 Business Overview
2.11.2 Immunofluorescence Assay Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vector Laboratories Immunofluorescence Assay Revenue, Gross Margin and Market Share (2016-2017)
3 Global Immunofluorescence Assay Market Competition, by Players
3.1 Global Immunofluorescence Assay Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Immunofluorescence Assay Players Market Share
3.2.2 Top 10 Immunofluorescence Assay Players Market Share
3.3 Market Competition Trend
4 Global Immunofluorescence Assay Market Size by Regions
4.1 Global Immunofluorescence Assay Revenue and Market Share by Regions
4.2 North America Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
4.3 Europe Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
4.5 South America Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
5 North America Immunofluorescence Assay Revenue by Countries
5.1 North America Immunofluorescence Assay Revenue by Countries (2013-2018)
5.2 USA Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
5.3 Canada Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
5.4 Mexico Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
6 Europe Immunofluorescence Assay Revenue by Countries
6.1 Europe Immunofluorescence Assay Revenue by Countries (2013-2018)
6.2 Germany Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
6.3 UK Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
6.4 France Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
6.5 Russia Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
6.6 Italy Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Immunofluorescence Assay Revenue by Countries
7.1 Asia-Pacific Immunofluorescence Assay Revenue by Countries (2013-2018)
7.2 China Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
7.3 Japan Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
7.4 Korea Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
7.5 India Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
8 South America Immunofluorescence Assay Revenue by Countries
8.1 South America Immunofluorescence Assay Revenue by Countries (2013-2018)
8.2 Brazil Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
8.3 Argentina Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
8.4 Colombia Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Immunofluorescence Assay by Countries
9.1 Middle East and Africa Immunofluorescence Assay Revenue by Countries (2013-2018)
9.2 Saudi Arabia Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
9.3 UAE Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
9.4 Egypt Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
9.5 Nigeria Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
9.6 South Africa Immunofluorescence Assay Revenue and Growth Rate (2013-2018)
10 Global Immunofluorescence Assay Market Segment by Type
10.1 Global Immunofluorescence Assay Revenue and Market Share by Type (2013-2018)
10.2 Global Immunofluorescence Assay Market Forecast by Type (2018-2023)
10.3 Indirect Immunofluorescence Revenue Growth Rate (2013-2023)
10.4 Direct Immunofluorescence Revenue Growth Rate (2013-2023)
11 Global Immunofluorescence Assay Market Segment by Application
11.1 Global Immunofluorescence Assay Revenue Market Share by Application (2013-2018)
11.2 Immunofluorescence Assay Market Forecast by Application (2018-2023)
11.3 Cancer Revenue Growth (2013-2018)
11.4 Infectious Diseases Revenue Growth (2013-2018)
11.5 Autoimmune Diseases Revenue Growth (2013-2018)
11.6 Cardiovascular Diseases Revenue Growth (2013-2018)
11.7 Other Diseases Revenue Growth (2013-2018)
12 Global Immunofluorescence Assay Market Size Forecast (2018-2023)
12.1 Global Immunofluorescence Assay Market Size Forecast (2018-2023)
12.2 Global Immunofluorescence Assay Market Forecast by Regions (2018-2023)
12.3 North America Immunofluorescence Assay Revenue Market Forecast (2018-2023)
12.4 Europe Immunofluorescence Assay Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Immunofluorescence Assay Revenue Market Forecast (2018-2023)
12.6 South America Immunofluorescence Assay Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Immunofluorescence Assay Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Immunofluorescence Assay Picture
Table Product Specifications of Immunofluorescence Assay
Table Global Immunofluorescence Assay and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
